Jean Jacques Bienaime Incyte Corp (INCY) insider trading activity

Jean Jacques Bienaime is Director of INCYTE CORP. Currently has a direct ownership of 20,841 shares of INCY, which is worth approximately $1.43 Million. The most recent transaction as insider was on Jun 10, 2025, when has been sold 2,518 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.8K

13.74% 3M change

13.74% 12M change

Total Value Held $1.43 Million

JEAN JACQUES BIENAIME Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2025	BUY Grant, award, or other acquisition	-	2,518 Added 10.78%	20,841 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	2,830 Added 13.38%	18,323 Common Stock
Jun 14 2023	BUY Grant, award, or other acquisition	-	2,505 Added 13.92%	15,493 Common Stock
Jun 15 2022	BUY Grant, award, or other acquisition	-	2,144 Added 14.17%	12,988 Common Stock
May 26 2021	BUY Grant, award, or other acquisition	-	1,923 Added 15.06%	10,844 Common Stock
Dec 31 2020	BUY Grant, award, or other acquisition	$23,920 $86.98 p/Share	275 Added 2.99%	8,921 Common Stock
Nov 10 2020	SELL Open market or private sale	$66,234 $83.0 p/Share	798 Reduced 8.45%	8,646 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	$22,794 $89.74 p/Share	254 Added 2.62%	9,444 Common Stock

Also insider at

BMRN

BIOMARIN PHARMACEUTICAL INC Healthcare

Director

IMNM

Immunome Inc. Healthcare

KROS

Keros Therapeutics, Inc. Healthcare

JJB